Skip to main content

View full-text article in PMC

. 2019 May 13;27(6):803–816. doi: 10.1016/j.jsps.2019.05.002

Table 4.

Effect of GLB, MCFE and their combination on serum levels of FBG in STZ-diabetic rats.

Treatment groups	FBG (mg/dL)
Treatment groups	0-time	2 week	4 weeks	8 weeks
NC	96.3 ± 5.43^b, ^c	95.7 ± 5.57^b, ^c	95.2 ± 5.32^b, ^c	95.3 ± 6.67^b, ^c
DC (STZ)	349.2 ± 7.57^a	351.5 ± 18.72^a, ^c	364.8 ± 16.35^a, ^c	365.8 ± 17.71^a, ^c
GLB	339.4 ± 9.87^a	166.3 ± 8.15^a, ^b	162.6 ± 8.23^a, ^b	143.5 ± 7.34^a, ^b
MCFE-250	347.1 ± 5.08^a	192.7 ± 9.22^a, ^b	189.1 ± 9.08^a, ^b	166.8 ± 8.70^a, ^b
MCFE-500	345.9 ± 7.66^a	158.8 ± 9.63^a, ^b	142.2 ± 7.32^a, ^b	133.2 ± 6.72^a, ^b
GLB + MCFE-250	347.8 ± 8.97^a	150.9 ± 5.30^a, ^b	138.3 ± 7.57^a, ^b	130.3 ± 6.46^a, ^b
GLB + MCFE-500	358.5 ± 6.98^a	119.6 ± 7.15^a,^b, ^c	106.1 ± 6.06^b, ^c	100.50 ± 5.89^b, ^c

Values are expressed as mean ± SE (n = 6).

Multiple group comparisons were performed by analysis of variance (ANOVA) followed by Tukey’s multiple comparison post hoc test at p ≤ 0.05.

^a

P ≤ 0.05, statistically significant from the normal control (NC) group.

^b

P ≤ 0.05, statistically significant from the diabetic control (DC) group.

^c

P ≤ 0.05, statistically significant from GLB group.